[财迷] [得意]_老虎社区_美港股上老虎 - 老虎社区

[财迷] [得意]

诺华制药分拆Sandoz将于9月15日等待股东批准

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

1

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":210229496569928,"tweetId":"210229496569928","gmtCreate":1692346044634,"gmtModify":1692346045817,"author":{"id":4091320857230770,"idStr":"4091320857230770","authorId":4091320857230770,"authorIdStr":"4091320857230770","name":"文狸","avatar":"https://static.tigerbbs.com/6e0accf8ec1b32c54695421b619b4620","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":2,"crmLevelSwitch":0,"currentWearingBadge":{"badgeId":"e2c640e5de444f3b84fa7170b007e676-1-09988","templateUuid":"e2c640e5de444f3b84fa7170b007e676","name":"“阿里巴巴-SW”人气虎","description":"一周内发布的“阿里巴巴-SW”相关帖子优质程度排名前3","bigImgUrl":"https://static.tigerbbs.com/2ba70f50467799d43bcf1b3972785ba7","smallImgUrl":"https://static.tigerbbs.com/5ecd4bad5ec93214c9325a5452cdd1b5","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stamp":"09988","stampPosition":0,"hasStamp":1,"allocationCount":4,"allocatedDate":"2021.12.22","individualDisplayEnabled":0},"individualDisplayBadges":[],"fanSize":20,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"html":"<html><head></head><body><p><span>[财迷]&nbsp;</span><span>[得意]&nbsp;</span></p></body></html>","htmlText":"<html><head></head><body><p><span>[财迷]&nbsp;</span><span>[得意]&nbsp;</span></p></body></html>","text":"[财迷] [得意]","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/210229496569928","repostId":2360901379,"repostType":2,"repost":{"id":"2360901379","pubTimestamp":1692345286,"share":"https://www.laohu8.com/m/news/2360901379?lang=&edition=full","pubTime":"2023-08-18 15:54","market":"other","language":"zh","title":"诺华制药分拆Sandoz将于9月15日等待股东批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2360901379","media":"智通财经网","summary":"瑞士制药巨头诺华制药周五发出邀请，将于9月15日召开特别股东大会，讨论剥离旗下仿制药公司Sandoz的相关事宜。诺华董事会已经批准了该提议。分拆计划预计将在10月4日左右进行。这家瑞士制药巨头表示，分拆将通过向现有股东分配Sandoz股份的提议进行，股东每持有5股诺华股票将获得1股Sandoz股票，或者每5股诺华美国存托凭证将获得1股Sandoz美国存托凭证。这些美国存托凭证不会在美国国内交易所上市。","content":"<html><head></head><body><p>瑞士制药巨头诺华制药周五发出邀请，将于9月15日召开特别股东大会，讨论剥离旗下仿制药公司Sandoz的相关事宜。</p><p style=\"text-align: justify;\">瑞士制药巨头诺华制药周五发出邀请，将于9月15日召开特别股东大会，讨论剥离旗下仿制药公司Sandoz的相关事宜。诺华董事会已经批准了该提议。分拆计划预计将在10月4日左右进行。</p><p style=\"text-align: justify;\">这家瑞士制药巨头表示，分拆将通过向现有股东分配Sandoz股份的提议进行，股东每持有5股诺华股票将获得1股Sandoz股票，或者每5股诺华美国存托凭证(ADR)将获得1股Sandoz美国存托凭证。</p><p style=\"text-align: justify;\">一旦获得批准，Sandoz将在瑞士证券交易所上市，并在美国进行ADR（美国存托凭证）计划。这些美国存托凭证不会在美国国内交易所上市。</p></body></html>","source":"highlight_zhitongcaijin","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>诺华制药分拆Sandoz将于9月15日等待股东批准</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n诺华制药分拆Sandoz将于9月15日等待股东批准\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-08-18 15:54 北京时间&nbsp;&nbsp;&nbsp;<a href=https://finance.sina.com.cn/stock/hkstock/ggscyd/2023-08-18/doc-imzhrfzf5892371.shtml><strong>智通财经网</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>瑞士制药巨头诺华制药周五发出邀请，将于9月15日召开特别股东大会，讨论剥离旗下仿制药公司Sandoz的相关事宜。瑞士制药巨头诺华制药周五发出邀请，将于9月15日召开特别股东大会，讨论剥离旗下仿制药公司Sandoz的相关事宜。诺华董事会已经批准了该提议。分拆计划预计将在10月4日左右进行。这家瑞士制药巨头表示，分拆将通过向现有股东分配Sandoz股份的提议进行，股东每持有5股诺华股票将获得1股...</p>\n\n<a href=\"https://finance.sina.com.cn/stock/hkstock/ggscyd/2023-08-18/doc-imzhrfzf5892371.shtml\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","relate_stocks":{"IE0002141913.USD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (USD) ACC","NVS":"诺华","BK4578":"CAR-T","IE00B2B36J28.USD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I1\" (USD) INC","IE00BJT1NW94.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (SGDHDG) ACC","BK1191":"制药","IE00BJJMRZ35.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (SGDHDG) ACC","BK4007":"制药","BK4585":"ETF&股票定投概念","IE00BFTCPJ56.SGD":"Janus Henderson Global Life Sciences A Acc SGD","BK1574":"生物医药B类股","IE0009355771.USD":"骏利亨德森环球生命科技A Acc","BK4532":"文艺复兴科技持仓","LU0211331839.USD":"FRANKLIN MUTUAL GLB DISCOVERY \"A\" (USD) ACC"},"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2023-08-18/doc-imzhrfzf5892371.shtml","is_english":false,"share_image_url":"https://static.laohu8.com/6ca2dcdccfa2217fb20a0351f4efe814","article_id":"2360901379","content_text":"瑞士制药巨头诺华制药周五发出邀请，将于9月15日召开特别股东大会，讨论剥离旗下仿制药公司Sandoz的相关事宜。瑞士制药巨头诺华制药周五发出邀请，将于9月15日召开特别股东大会，讨论剥离旗下仿制药公司Sandoz的相关事宜。诺华董事会已经批准了该提议。分拆计划预计将在10月4日左右进行。这家瑞士制药巨头表示，分拆将通过向现有股东分配Sandoz股份的提议进行，股东每持有5股诺华股票将获得1股Sandoz股票，或者每5股诺华美国存托凭证(ADR)将获得1股Sandoz美国存托凭证。一旦获得批准，Sandoz将在瑞士证券交易所上市，并在美国进行ADR（美国存托凭证）计划。这些美国存托凭证不会在美国国内交易所上市。","news_type":1},"isVote":1,"tweetType":1,"viewCount":158,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":12,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/210229496569928"}